StockData
Cellyan Biotechnology Co., Ltd logo

Cellyan Biotechnology Co., Ltd (HKPD) stock

HKPDNasdaqWholesale-Drugs, Proprietaries & Druggists' SundriesFiscal year ends March 31
Financials through fiscal 2026, year ended Mar 31, 2026Last filing: 20-F on Aug 7, 2026Score 3/30
$1.52−0.09 (-5.30%)

Close on Nov 17, 2026Market cap $24.93MP/E –Yield –

Cellyan Biotechnology price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

Cellyan Biotechnology's price to sales ratio was 2.0× on Nov 11, 2026, against 9.9× a year earlier.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20262.0×+1.6
2025Dec 31, 20250.4×–

More Cellyan Biotechnology figures

See a number that looks wrong?